Form D — Thiogenesis Therapeutics, Corp.
0001062993-26-003123 · filed Jun 9, 2026
Offering
- Industry
- Biotechnology
- Exemptions
- 06b
- Total offering
- $28,964
- Total sold
- $28,964
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Thiogenesis Therapeutics, Corp.
- CIK
- 1877778
- Entity
- Corporation
- Jurisdiction
- ONTARIO, CANADA
- Year incorporated
- —
- Address
- 4 KING STREET WEST, SUITE 401
TORONTO, A6 M5H 1B6 - Phone
- (888) 223-9165
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Brook G. Riggins · Executive OfficerToronto, A6 Find on LinkedIn ↗
-
Patrice Rioux · Executive OfficerToronto, A6 Find on LinkedIn ↗
-
W. Hogan Mullally · DirectorToronto, A6 Find on LinkedIn ↗
-
Kim Tsuchimoto · DirectorToronto, A6 Find on LinkedIn ↗
-
Christopher Starr · DirectorToronto, A6 Find on LinkedIn ↗
View the original filing on SEC EDGAR ↗